Does TOFACITINIB Cause Psoriatic arthropathy? 2,810 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,810 reports of Psoriatic arthropathy have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.8% of all adverse event reports for TOFACITINIB.
2,810
Reports of Psoriatic arthropathy with TOFACITINIB
1.8%
of all TOFACITINIB reports
1,546
Deaths
1,632
Hospitalizations
How Dangerous Is Psoriatic arthropathy From TOFACITINIB?
Of the 2,810 reports, 1,546 (55.0%) resulted in death, 1,632 (58.1%) required hospitalization, and 1,755 (62.5%) were considered life-threatening.
Is Psoriatic arthropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 2,810 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Psoriatic arthropathy?
SECUKINUMAB (8,900)
ADALIMUMAB (8,148)
METHOTREXATE (7,167)
APREMILAST (7,035)
ETANERCEPT (6,518)
CERTOLIZUMAB PEGOL (5,798)
LEFLUNOMIDE (4,703)
INFLIXIMAB (4,238)
GOLIMUMAB (4,101)
SULFASALAZINE (3,961)
Which TOFACITINIB Alternatives Have Lower Psoriatic arthropathy Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN